期刊文献+

人脑胶质瘤高表达Snail促进肿瘤细胞的侵袭 被引量:8

Human glioma expresses high level of Snail and promotes tumor cell invasiveness
原文传递
导出
摘要 目的:观察Snail蛋白在人脑胶质瘤组织中的表达情况,探讨Snail表达对人脑胶质瘤U251细胞侵袭的影响。方法:收集首都医科大学附属北京天坛医院及北京安贞医院神经外科手术切除的脑胶质瘤组织65例,应用免疫组织化学S-P法检测人脑胶质瘤组织中Snail的表达。体外化学合成Snail序列特异性小干扰RNA(Snail-siRNA),应用脂质体介导转染U251细胞;RT-PCR、Western blotting检测转染后U251细胞中Snail mRNA和蛋白、E-cadherin蛋白表达水平变化,并采用Transwell小室检测转染后U251细胞侵袭能力的变化。结果:与正常脑组织相比,人脑胶质瘤组织中Snail蛋白阳性表达率明显增强(66.2%vs0,P<0.01),并且Ⅰ~Ⅱ级的胶质瘤组织阳性Snail阳性率明显低于Ⅲ~Ⅳ级(44.8%vs83.3%,P<0.01)。Snail-siRNA转染抑制U251细胞中Snail mRNA和蛋白的表达。Snail-siRNA转染组U251细胞中E-cadherin蛋白的表达明显高于Ctrl-siRNA组与未转染组(0.64±0.21vs0.15±0.16,0.21±0.19,P<0.01)。Snail-siRNA转染显著抑制U251细胞的侵袭(87.0±2.4vs140.0±4.9,136.0±5.3;P<0.05)。结论:人脑胶质瘤组织高表达Snail蛋白,siRNA干扰Snail蛋白的表达可抑制胶质瘤U251细胞的侵袭。 Objective:To investigate the expression of Snail protein in human glioma tissues and study the effect of Snail on human glioma U251 cells. Methods:Sixty-five specimens from glioma patients,who were diagnosed in Beijing Anzhen Hospital and Beijing Tiantan Hospital,were included in this study. Immunohistochemistry S-P was used to detect Snail protein expression in human glioma tissues. Snail specific small interference RNA (Snail-siRNA) was constructed and transfected into U251 cells by lipofectamine. The expressions of Snail mRNA and protein and E-cadherin protein in transfected-U251 cells were investigated by RT-PCR and Western blotting analysis,respectively; and the invasion ability of transfected-U251 cells was investigated by Transwell chamber assay. Results:The positive rate of Snail was 66.2% in human glioma,which was significantly higher than that in the normal brain tissues (0%,P〈0.01),and Snail positive rate in Ⅰ-Ⅱ stage glioma was significantly lower than that in Ⅲ-Ⅳ stage glioma (44.8% vs 83.3%,P〈0.01). Snail-siRNA transfection inhibited the expressions of Snail mRNA and protein. The expression of E-cadherin protein in Snail-siRNA transfected-U251 cells was significantly increased compared with those in Ctrl-siRNA and untransfected groups (0.64±0.21 vs 0.15±0.16,0.21±0.19,P〈0.01). Snail-siRNA transfection inhibited the invasion of U251 cells (87.0±2.4 vs 140.0±4.9,136.0±5.3; P〈0.05). Conclusion:Snail protein is highly expressed in human glioma tissues,and siRNA interfering the expression of Snail protein can inhibit invasion of glioma U251 cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2011年第1期80-83,共4页 Chinese Journal of Cancer Biotherapy
关键词 胶质瘤 SNAIL RNA干扰 侵袭 glioma Snail RNA interference invasion
  • 相关文献

参考文献17

  • 1晏怡,唐文渊,邓朝霞.替莫唑胺治疗复发性胶质瘤的疗效分析[J].肿瘤防治研究,2010,37(1):91-94. 被引量:5
  • 2潘志刚,刘文超,孙宏邵,江澜,岳亚军,蔡伟,杨剑,薛安琳,刘汉山.血管生成抑制素对C6脑胶质瘤的抑瘤效应[J].肿瘤防治研究,2010,37(4):392-394. 被引量:1
  • 3Narkiewicz J, Lapinska-Szumczyk S, Zurawa-Janicka D, et al. Expression of human HtrAl, HtrA2, HtrA3 and TGF-betal genes in primary endometrial cancer [J]. Oncol Rep, 2009, 21 (6): 1529-1537.
  • 4Maelandsmo GM, Flcrenes VA, Nguyen MT, et al. Different ex-pression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites [J]. Tumor Biol, 2009, 30( 1 ) : 15-25.
  • 5Langer R, Feith M, Siewert JR, et al. Expression and clinical sig- nificance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus [ J ]. BMC Cancer, 2008, 8: 70.
  • 6Yin T, Wang C, Liu T, et al. Expression of snail in pancreatic cancer promotes metastasis and chemoresistance [ J ]. J Surg Res, 2007, 141(2): 196-203.
  • 7Anthony J, Trimboli, Fukino K, et al. Direct evidence for epithe- lial-mesenchymal transitions in breast cancer [ J ]. Cancer Res, 2008, 68 (3) : 937-945.
  • 8Galvan JA, Gonzalez MV, Crespo G, et al. Snail nuclear expres- sion parallels higher malignancy potential in neuroendocrine lung tumors [Jl. Lung Cancer, 2010, 69(3) : 289-295.
  • 9Nieto MA. The snail superfamily of zinc-finger transcription factors [J]. Nat Rev Mol Cell Biol, 2002, 3(3) : 155-166.
  • 10Elloul S, Elstrand MB, Nesland JM, et al. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggres- siveness in metastatic ovarian and breast carcinoma [ J ]. Cancer, 2005, 103(8): 1631-1643.

二级参考文献20

  • 1赵澎,张亚卓.鼠胶质瘤动物模型的建立及应用[J].国外医学(神经病学.神经外科学分册),2005,32(1):38-41. 被引量:6
  • 2曾宪起,申长虹,浦佩玉,杨树源.应用替莫唑胺对照司莫司丁治疗恶性脑胶质瘤的疗效观察[J].中华神经外科杂志,2006,22(4):204-207. 被引量:50
  • 3邓万凯,黄书岚.恶性胶质瘤术后应用替莫唑胺化疗联合放疗的临床观察[J].肿瘤防治研究,2006,33(10):758-760. 被引量:14
  • 4Chinot OL, Barrie M. Frauger E, et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma muhiforme in an elderly populalions[J]. Cancer, 2004, 100(10): 2208- 2214.
  • 5Kobayashi H, Sawamura Y, lshii N, et al. Temozolomide in the treatment of recurrent malignant glioma[J]. No Shinkei Geka, 2006.34(12): 1241-1247.
  • 6Chang SM, Theodosopoulos P, Lamborn K, et al. Ternozolomide in the treatment of recurrent malignant glioma[J]. Cancer,2004, 100(3) :605- 611.
  • 7Wick A, Felsberg J, Steinbach JP, el al. Efficacy and tolerability of temozolomide in an alternating weekly regimen in pa tients with recurrent glioma[J]. J Clin Oncol, 2007,25 (22) : 3357- 3361.
  • 8Brandes AA, Tosoni A, Cavallo G, et al. Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo dineurcroncologia (GICNO)[J]. Br J Cancer, 2006,95(9) : 1155- 1160.
  • 9Wick W, Steinbach JP, Kuker WM, et al. One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma[J]. Neurology, 2004,62( 11 ) :2113- 2115.
  • 10Tosoni A, Francesehi E. Ermani M, et al. Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliornas[J]. J Neurooncol, 2008.89(2):179- 185.

共引文献4

同被引文献89

  • 1许乐,林宗明,朱煜,王国民.过度活化Notch1信号促进肾癌细胞增殖的机制研究[J].肿瘤防治研究,2014,41(2):114-118. 被引量:5
  • 2范存刚,张庆俊.肿瘤坏死因子相关凋亡诱导配体治疗脑胶质瘤的研究进展[J].肿瘤防治研究,2014,41(2):168-172. 被引量:7
  • 3Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature ,2008,455 : 1061-1068.
  • 4Brauksiepe B, Mujica AO, Herrmann H, et al. The Serine/threonine kinase Stk33 exhibits autophosphorylation and phospho- rylates the intermediate filament protein Vimentin. BMC Bioehem,2008,9:25.
  • 5Helfand BT, Mendez MG, Murthy SN,et al. Vimentin organization modulates the formation of lamellipodia. Mol Biol Cell, 2011,22 : 1274-1289.
  • 6Paccione RJ, Miyazaki H, Patel V,et al. Keratin down-regulation in vimentin-posi- tive cancer ceils is reversible by vimentin RNA interference, which inhibits growth and motility. Mol Cancer Ther, 2008,7 : 2894-2903.
  • 7Cancer Genome Atlas Research Network. Comprehensive genomic characterizationdefines human gliob[astoma genes and core path- ways[J].Nature,2008,455(7216):1061-1068.
  • 8Wen PY,KesariS. Malignant gliomasinadults[J]. N EnglJ Med, 2008,359(5) :492- 507.
  • 9Omar Flores, Kerry L. Burnstein, Nuclear Targeting of Cyclin-De pendent Kinase 2 Reveals Essential Roles of Cyclin-Dependent Ki nase 2 Localization and Cyclin E in Vitamin D-Mediated Growth lnhibition[J]. Endocrinology, 2010,151 (3) : 896-908.
  • 10Xue JD,Anding L,Zhuan Z, et al. siRNA inhibition of telomerase enhances the anti cancer effect of doxorubicin in breast cancer cells[J]. BMC Cancer, 2009,9 : 133.

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部